CTIC logo

CTI BioPharma (CTIC) Working Capital

Annual Working Capital

$18.26 M
+$16.53 M+956.83%

December 31, 2022

Summary

Performance

1-Year Change

+956.83%

3-Year Change

+6.85%

5-Year Change

-33.99%

15-Year Change

-33.99%

CTIC Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$250.14 M
CTIC annual working capital is currently -92.70% below its historical high of $250.14 million

3-Year Low

$1.73 M
CTIC annual working capital is currently +956.83% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Annual Book Value

-$17.58 M
CTIC annual book value is -$17.58 million

Annual Retained Earnings

-$2.52 B
CTIC annual retained earnings is -$2.52 billion

Annual Total Assets

$125.92 M
CTIC annual total assets is $125.92 million

Annual Total Liabilities

$143.50 M
CTIC annual total liabilities is $143.50 million

Quarterly Working Capital

$18.23 M
-$35.00 K-0.19%

March 31, 2023

Summary

Performance

3-Month Change

-0.19%

1-Year Change

+318.92%

3-Year Change

-73.29%

5-Year Change

-79.17%

CTIC Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$272.27 M
CTIC quarterly working capital is currently -93.31% below its historical high of $272.27 million

3-Year Low

$1.73 M
CTIC quarterly working capital is currently +954.80% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Quarterly Book Value

-$25.35 M
CTIC quarterly book value is -$25.35 million

Quarterly Retained Earnings

-$2.53 B
CTIC quarterly retained earnings is -$2.53 billion

Quarterly Total Assets

$112.27 M
CTIC quarterly total assets is $112.27 million

Quarterly Total Liabilities

$137.62 M
CTIC quarterly total liabilities is $137.62 million

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

Annual Working Capital

$18.26 M
CTIC annual working capital is $18.26 million

Annual Current Assets

$99.40 M
CTIC annual total current assets is $99.40 million

Annual Current Liabilities

$81.13 M
CTIC annual total current liabilities is $81.13 million

CTIC Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+956.8%+318.9%
3 y3 years+6.8%-73.3%
5 y5 years-34.0%-79.2%

CTIC Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-90.5%-76.5%-90.5%
5 y5-year-51.0%-90.5%-76.5%-90.5%
alltimeall time-92.7%-269.3%-93.3%-286.1%

CTI BioPharma Working Capital History

DateAnnualQuarterly
Mar 2023
-
$18.23 M(-0.2%)
Dec 2022
$18.26 M(+956.8%)
$18.26 M(-72.8%)
Sep 2022
-
$67.17 M(-13.4%)
Jun 2022
-
$77.58 M(+1683.1%)
Mar 2022
-
$4.35 M(+151.8%)
Dec 2021
$1.73 M(-95.4%)
$1.73 M(-95.3%)
Sep 2021
-
$36.70 M(-37.8%)
Jun 2021
-
$59.03 M(+148.1%)
Mar 2021
-
$23.79 M(-36.2%)
Dec 2020
$37.29 M(+118.2%)
$37.29 M(-15.6%)
Sep 2020
-
$44.17 M(-23.6%)
Jun 2020
-
$57.78 M(-15.3%)
Mar 2020
-
$68.23 M(+299.2%)
Dec 2019
$17.09 M(-71.2%)
$17.09 M(-21.4%)
Sep 2019
-
$21.75 M(-43.7%)
Jun 2019
-
$38.65 M(-21.7%)
Mar 2019
-
$49.37 M(-16.9%)
Dec 2018
$59.44 M(+114.8%)
$59.44 M(+0.2%)
Sep 2018
-
$59.30 M(-18.6%)
Jun 2018
-
$72.82 M(-16.8%)
Mar 2018
-
$87.52 M(+216.3%)
Dec 2017
$27.67 M(+82.3%)
$27.67 M(-11.6%)
Sep 2017
-
$31.30 M(-25.3%)
Jun 2017
-
$41.90 M(-920.9%)
Mar 2017
-
-$5.10 M(-133.6%)
Dec 2016
$15.18 M(-75.7%)
$15.18 M(-29.8%)
Sep 2016
-
$21.62 M(-55.1%)
Jun 2016
-
$48.15 M(-28.8%)
Mar 2016
-
$67.59 M(+8.0%)
Dec 2015
$62.57 M(+41.7%)
$62.57 M(+271.3%)
Sep 2015
-
$16.85 M(-45.2%)
Jun 2015
-
$30.77 M(+70.1%)
Mar 2015
-
$18.08 M(-59.1%)
Dec 2014
$44.16 M(-26.9%)
$44.16 M(+62.8%)
Sep 2014
-
$27.13 M(+47.0%)
Jun 2014
-
$18.46 M(-55.9%)
Mar 2014
-
$41.81 M(-30.8%)
Dec 2013
$60.45 M(+60.6%)
$60.45 M(+357.3%)
Sep 2013
-
$13.22 M(+1.4%)
Jun 2013
-
$13.03 M(-56.6%)
Mar 2013
-
$30.05 M(-20.2%)
Dec 2012
$37.64 M(+13.1%)
$37.64 M(-632.8%)
Sep 2012
-
-$7.07 M(-39.0%)
Jun 2012
-
-$11.58 M(-168.4%)
Mar 2012
-
$16.94 M(-49.1%)
Dec 2011
$33.29 M(-335.0%)
$33.29 M(+74.3%)
Sep 2011
-
$19.10 M(+217.4%)
Jun 2011
-
$6.02 M(-29.3%)
Mar 2011
-
$8.51 M(-160.1%)
Dec 2010
-$14.16 M(-34.7%)
-$14.16 M(+144.6%)
Sep 2010
-
-$5.79 M(-275.8%)
Jun 2010
-
$3.29 M(-122.1%)
Mar 2010
-
-$14.89 M(-31.4%)
DateAnnualQuarterly
Dec 2009
-$21.69 M(+53.4%)
-$21.69 M(+62.1%)
Sep 2009
-
-$13.38 M(-11.6%)
Jun 2009
-
-$15.13 M(-33.6%)
Mar 2009
-
-$22.78 M(+61.1%)
Dec 2008
-$14.14 M(-54.2%)
-$14.14 M(-285.5%)
Sep 2008
-
$7.63 M(-352.2%)
Jun 2008
-
-$3.02 M(-85.2%)
Mar 2008
-
-$20.39 M(-34.0%)
Dec 2007
-$30.91 M(-202.5%)
-$30.91 M(-8.9%)
Sep 2007
-
-$33.92 M(+58.3%)
Jun 2007
-
-$21.43 M(-188.4%)
Mar 2007
-
$24.24 M(-19.7%)
Dec 2006
$30.17 M(-60.5%)
$30.17 M(-36.6%)
Sep 2006
-
$47.58 M(+27.9%)
Jun 2006
-
$37.21 M(+22.0%)
Mar 2006
-
$30.50 M(-60.0%)
Dec 2005
$76.29 M(-18.7%)
$76.29 M(-1546.8%)
Sep 2005
-
-$5.27 M(+68.3%)
Jun 2005
-
-$3.13 M(-105.5%)
Mar 2005
-
$57.25 M(-39.0%)
Dec 2004
$93.81 M(+30.5%)
$93.81 M(+8.1%)
Sep 2004
-
$86.75 M(+21.3%)
Jun 2004
-
$71.52 M(-34.5%)
Mar 2004
-
$109.24 M(+51.9%)
Dec 2003
$71.90 M(-44.6%)
$71.90 M(-36.2%)
Sep 2003
-
$112.74 M(-21.8%)
Jun 2003
-
$144.25 M(+42.5%)
Mar 2003
-
$101.24 M(-22.0%)
Dec 2002
$129.85 M(-48.1%)
$129.85 M(-16.5%)
Sep 2002
-
$155.45 M(-16.8%)
Jun 2002
-
$186.85 M(-17.4%)
Mar 2002
-
$226.17 M(-9.6%)
Dec 2001
$250.14 M(+70.9%)
$250.14 M(-8.1%)
Sep 2001
-
$272.27 M(+1.7%)
Jun 2001
-
$267.77 M(+95.2%)
Mar 2001
-
$137.16 M(-6.3%)
Dec 2000
$146.38 M(+727.0%)
$146.38 M(-5.6%)
Sep 2000
-
$155.09 M(+351.4%)
Jun 2000
-
$34.35 M(-20.2%)
Mar 2000
-
$43.04 M(+143.1%)
Dec 1999
$17.70 M(-59.9%)
$17.70 M(+5.4%)
Sep 1999
-
$16.80 M(-36.6%)
Jun 1999
-
$26.50 M(-26.8%)
Mar 1999
-
$36.20 M(-17.9%)
Dec 1998
$44.10 M(-34.9%)
$44.10 M(-13.9%)
Sep 1998
-
$51.20 M(-7.1%)
Jun 1998
-
$55.10 M(-9.5%)
Mar 1998
-
$60.90 M(-10.0%)
Dec 1997
$67.70 M(+157.4%)
$67.70 M(+67.2%)
Sep 1997
-
$40.50 M(-10.2%)
Jun 1997
-
$45.10 M(-10.5%)
Mar 1997
-
$50.40 M
Dec 1996
$26.30 M
-

FAQ

  • What is CTI BioPharma annual working capital?
  • What is the all time high annual working capital for CTI BioPharma?
  • What is CTI BioPharma annual working capital year-on-year change?
  • What is CTI BioPharma quarterly working capital?
  • What is the all time high quarterly working capital for CTI BioPharma?
  • What is CTI BioPharma quarterly working capital year-on-year change?

What is CTI BioPharma annual working capital?

The current annual working capital of CTIC is $18.26 M

What is the all time high annual working capital for CTI BioPharma?

CTI BioPharma all-time high annual working capital is $250.14 M

What is CTI BioPharma annual working capital year-on-year change?

Over the past year, CTIC annual working capital has changed by +$16.53 M (+956.83%)

What is CTI BioPharma quarterly working capital?

The current quarterly working capital of CTIC is $18.23 M

What is the all time high quarterly working capital for CTI BioPharma?

CTI BioPharma all-time high quarterly working capital is $272.27 M

What is CTI BioPharma quarterly working capital year-on-year change?

Over the past year, CTIC quarterly working capital has changed by +$13.88 M (+318.92%)